Nansha to expand opening-up pilot work in medical field

Nansha district plans to expand its opening-up pilot work in the medical field shortly.

The national negative list for foreign investment access restrictions has been reduced from 31 to 29 measures, with foreign investment access restrictions in the manufacturing sector achieving "zero". These measures will further promote Nansha as an open district.

Nansha is developing the biopharmaceutical industry, attracting over 400 companies in various areas, such as immunotherapy, stem cells, and regenerative medicine.

Nansha allows foreign-invested enterprises to develop and apply human stem cells, gene diagnosis, and treatment technologies for product registration and production.

In August of this year, the Greater Bay Area Digital Economy and Life Sciences Industrial Park, one of the "Six Parks" in Nansha, started construction.

Furthermore, Nansha permits the establishment of wholly foreign-owned hospitals in multiple cities to provide advanced medical technologies and services to the people. Nansha is currently planning the construction of six Grade A hospitals and is becoming a concentrated area of high-quality medical resources in the Greater Bay Area.

It also promotes open measures such as direct payment for cross-border medical insurance to support the more accessible cross-border flow of high-quality medical resources.

These measures will drive Nansha's integration into the international market and enhance the international cooperation and competitive advantages of the Guangdong-Hong Kong-Macao Greater Bay Area.

Rendering of the Greater Bay Area Digital Economy and Life Sciences Industrial Park. [Photo/WeChat account: gz_nanshafabu]